CTCBIO Inc (060590) — Cash Flow-to-Debt Ratio
CTCBIO Inc (060590) has a Cash Flow-to-Debt Ratio of 0.07x as of September 2025, meaning its operating cash flow of ₩5.64 Billion could theoretically repay 0% of its total liabilities (₩77.43 Billion) in one year. See 060590 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CTCBIO Inc Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for CTCBIO Inc across 12 annual periods. Also explore how fast is CTCBIO Inc growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for CTCBIO Inc (2013–2024)
Year-by-year debt coverage analysis for CTCBIO Inc. For market capitalisation and broader financial context, see CTCBIO Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.05x | ₩4.50 Billion | ₩84.07 Billion | ▼ -41.1% |
| 2023 | 0.09x | ₩8.22 Billion | ₩90.42 Billion | ▼ -54.2% |
| 2022 | 0.20x | ₩18.22 Billion | ₩91.94 Billion | ▲ +155.4% |
| 2021 | 0.08x | ₩6.46 Billion | ₩83.21 Billion | ▲ +1434.3% |
| 2020 | 0.01x | ₩510.09 Million | ₩100.86 Billion | ▼ -66.3% |
| 2019 | 0.01x | ₩1.68 Billion | ₩111.76 Billion | ▲ +163.5% |
| 2018 | -0.02x | ₩-2.47 Billion | ₩104.82 Billion | ▼ -1041.3% |
| 2017 | 0.00x | ₩295.30 Million | ₩117.82 Billion | ▼ -96.4% |
| 2016 | 0.07x | ₩6.86 Billion | ₩97.78 Billion | ▲ +361.4% |
| 2015 | 0.02x | ₩1.44 Billion | ₩94.47 Billion | ▲ +435.3% |
| 2014 | 0.00x | ₩-347.74 Million | ₩76.63 Billion | ▼ -109.6% |
| 2013 | 0.05x | ₩2.74 Billion | ₩58.25 Billion | — |